A congressional subcommittee is investigating whether the U.S. government is paying too much for ventilators made by a Dutch company that received millions in tax dollars to develop an affordable one for pandemics, but is now charging quadruple the price under a new deal.
Courts, Boards, & GAO
Trending Now
Phase One Fizzle: Protester’s Past Performance Doesn’t Make the Cut • Shipping Container Set-Aside Sinks: Was the Agency’s Market Research All at Sea? • “Let’s Just Agree to Never Speak of this Again”: ASBCA Refuses to Bury Decision as Condition of Settlement • RFO Consolidation Limitations Do Not Apply to BPAs, Says GAO • CAS Board Publishes Final Rule Rescinding CAS 404, 408, 409, and 4117
Congress Is Investigating Whether a Ventilator Company Is Gouging the U.S. — and Why the Government Is Letting It Happen
Get daily insights on bid protests, CDA claims, and contract litigation that shape the GovCon landscape with our Protests & Claims newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.